Indian Pharma Market Sees 8.7% Growth in January 2025, But Vaccines, Ophthalmology Struggle Farhat Nasim10 Feb 2025 6:47 PM ISTNew Delhi: The Indian pharmaceutical market (IPM) recorded an 8.7% year-on-year (YoY) growth in January 2025, reaching a monthly value of Rs 19,238...
Indian Pharma Market reaches Rs 19,083 crore in December, Check out top performing brands Farhat Nasim16 Jan 2025 7:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has experienced robust growth, reaching a market value of Rs 19,083 crore in December 2024. This...
NPPA to Re-Examine Iohexol Injection Price Challenged by JB Chemicals Farhat Nasim31 Dec 2024 6:47 PM ISTNew Delhi: In a respite to Mumbai-based JB Chemicals and Pharmaceuticals, the Department of Pharmaceuticals (DoP) has directed the National...
Indian Pharma Market Grows at 9.9%, Vaccine Sales See Sharp Decline: Pharmatrac Report Farhat Nasim16 Dec 2024 5:27 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) posted a solid 9.9% increase in value, reaching Rs 19,388 crore in November 2024. This growth was...
Glenmark's Win: NPPA revises price of Telmisartan, Cilnidipine FDC after data review Farhat Nasim3 Dec 2024 2:57 PM ISTNew Delhi: Drug maker, Glenmark Pharmaceuticals' appeal against the earlier price fixation for its cardiovascular drug combination, Cilnidipine 20 mg...
GSK's Augmentin Leads Indian Pharma Market in October with Rs 843 Crore Sales: Pharmatrac Report Farhat Nasim22 Nov 2024 5:40 PM ISTNew Delhi: As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the test of time...
NPPA Revises Ceiling Prices for 6 Drugs Including Clarithromycin, Vitamin C, Details Farhat Nasim20 Nov 2024 4:08 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced revised ceiling prices for six drug formulations following review orders...
DoP Dismisses Aristo Pharma's Plea to Reassess Multivitamin Tablet Pricing Set by NPPA Farhat Nasim10 Nov 2024 1:30 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) recently rejected Aristo Pharmaceuticals' application challenging the price set for its...
DoP upholds NPPA ceiling price fixation for Azoran 50mg tablet Farhat Nasim5 Nov 2024 6:10 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has upheld the ceiling price for Azathioprine 50mg tablets, as determined by the National...
DoP orders NPPA to reassess price of Cipla's Advent, Synclar and Azee drugs Farhat Nasim30 Oct 2024 6:14 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP), under the Ministry of Chemicals & Fertilizers, has issued orders to the National...
Rising public health concerns on antibiotic overuse in India: The Lancet Aditi13 Sept 2022 3:56 PM ISTAntibiotic resistance is a global health concern, making curing many infections expensive and impossible. The unwise use of antibiotics is driving...
